Price movement over the last 24 hours
Agilent Technologies Inc vs Amazon.com Inc — how do they compare? Agilent Technologies Inc trades at $128.62 (market cap $37.04B), while Amazon.com Inc trades at $241.85 (market cap $2.65T). The key difference: Amazon.com Inc is far larger — about 71.5× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| A | AMZN | |
|---|---|---|
Market Cap | $37.04B | $2.65T |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $274.95 |
52-Week Low | $110.24 | $198.79 |
Enterprise Value | $38.59B | $2.71T |
Dividend Yield | 0.78% | — |
Volume | — | 3,931,282 |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Amazon (AMZN) trades at $240.88, down 1.34% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamental performance with 2025 revenue reaching $716.92 billion and net income of $77.67 billion, representing a 10.83% margin. Recent Q1 2026 earnings beat expectations at $2.78 EPS versus $1.63 expected. Operating cash flow remains strong at $139.51 billion, though heavy investment spending creates negative investing cash flow.
Amazon presents a compelling investment case with strong revenue growth, expanding profitability, and dominant market positions in e-commerce and cloud computing. The primary risks include intense competition in retail and cloud services, significant capital expenditure requirements, and potential regulatory scrutiny. With 88% analyst buy ratings and a $321.11 consensus price target representing 33% upside, Wall Street remains bullish on Amazon's long-term prospects despite near-term valuation concerns.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →